CMIIU
FINANCIAL SERVICESColumbus Circle Capital Corp II - Units (1 Ord Cls A & 1/3 War)
Live · NASDAQ · May 9, Close
What's Moving CMIIU Today?
No stock-specific AI insight has been generated for CMIIU yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
CMIIU News
5 articles- Institutional Financial Markets Q1 Earnings Call HighlightsMarketbeat·May 2, 2026
- Cohen & Company Reports First Quarter 2026 Financial ResultsYahoo Finance·May 1, 2026
- Columbus Circle Capital Corp II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 27, 2026Yahoo Finance·Feb 26, 2026
- Columbus Circle Capital Corp. II and Cohen & Company Inc. Announce Completion of $230,000,000 Initial Public OfferingYahoo Finance·Feb 12, 2026
- Columbus Circle Capital Corp II Announces Pricing of $200,000,000 Initial Public OfferingYahoo Finance·Feb 10, 2026
All 5 articles loaded
Price Data
Fundamentals
Trading
About Columbus Circle Capital Corp II - Units (1 Ord Cls A & 1/3 War)
Columbus Circle Capital Corp II Unit (CMIIU) is a specialized acquisition vehicle focused on the life sciences sector, specifically targeting innovative biotechnology, pharmaceuticals, and healthcare companies poised for growth through strategic mergers and acquisitions. Led by a highly experienced management team with deep industry expertise, CMIIU is committed to fostering advancement in key areas such as therapeutics and diagnostics. The company is strategically positioned to capitalize on emerging healthcare trends, leveraging its resources to identify and partner with transformative enterprises that align with its commitment to sustainable innovation and shareholder value creation.